Categories AlphaGraphs, Earnings, Other Industries

Earnings preview: Teva’s struggles might not end in Q2

Teva Pharmaceuticals (NYSE: TEVA) is scheduled to report second quarter 2019 earnings results on Wednesday, August 7, before market open. Analysts expect to report earnings of $0.57 per share on revenue of $4.25 billion.

Teva has been struggling with tough competition and pricing challenges in the generics market and this is expected to continue in the second quarter. Revenue declines in Copaxone as well as other key brands is also expected to hurt the top line numbers. Teva is also likely to see pressure in Europe due to discontinued business operations.

Teva reports first quarter 2019 earnings results

However, the company is expected to benefit from the sales of new products which are likely to partially offset the weakness in other areas. Cost-saving efforts are expected to help margins during the quarter. Updates on the company’s new product launches and approvals for new indications are areas to keep an eye out for.

In the first quarter of 2019, Teva beat earnings estimates but revenues missed expectations. Revenues fell 15% to $4.3 billion while adjusted EPS dropped 36% to $0.60. Revenues decreased in all geographic regions. Generic products and Copaxone saw sales declines across all markets.  

For the full year of 2019, Teva has guided for revenues in the range of $17-17.4 billion and adjusted EPS in the range of $2.20-2.50.

Teva’s shares have dropped 50% year-to-date and 17% over the past one month. The majority of analysts have rated the stock Hold and it has a price target of $10.75.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

AVGO Earnings: Broadcom Q2 2024 revenue and profit beat estimates

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Wednesday reported higher second-quarter revenues and adjusted earnings. The results also topped analysts' expectations. Earnings, excluding non-recurring items, came in at $10.96 per

Key takeaways from Oracle’s (ORCL) Q4 2024 earnings report

Oracle Corporation’s (NYSE: ORCL) stock rallied this week after the company announced large cloud infrastructure deals with tech giants Google, OpenAI, and Microsoft. The demand for Oracle's generative AI infrastructure

ZDGE Earnings: Zedge reports higher revenues and adj. profit for Q3 2024

Content distribution platform Zedge, Inc. (NYSE American: ZDGE) has reported higher net income for the third quarter of 2024, on an adjusted basis. The bottom line benefitted from a double-digit

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top